Sydney Cancer Partners and Maridulu Budyari Gumal (SPHERE) Cancer CAG are pleased to announce that the Strategic Enhancement Grants are now open for Expressions of Interest.

This joint and co-funded initiative is designed to build translational cancer research capacity in NSW. The scheme will support leaders of mature, translational cancer research programs which span both SCP and SPHERE member institutions, to facilitate successful applications for significant funding from national (e.g., MRFF, NHMRC), international or commercial sources.

Up to $140,000 per annum for a maximum of 2 years is available (total maximum grant value $280,000). Up to two grants may be awarded.

How to apply:

The Strategic Enhancement Grants will be awarded following a two-stage process.

1. Expression of Interest

• A single Expression of Interest (EOI) should be submitted by two CIs, one from each of a SCP and SPHERE member organisation
• The EOI will include a short description of program scope, target funding scheme and proposed use of the award.
• EOIs will be evaluated by a joint SPHERE & SCP review panel.

2. Short-listed applicants will be invited to submit a full application in February 2023.